- Home
- APEI vs TSHA Comparison
APEI vs TSHA Comparison
Compare APEI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APEI
- TSHA
- Stock Information
- Founded
- APEI 1991
- TSHA 2019
- Country
- APEI United States
- TSHA United States
- Employees
- APEI N/A
- TSHA N/A
- Industry
- APEI Other Consumer Services
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- APEI Consumer Discretionary
- TSHA Health Care
- Exchange
- APEI Nasdaq
- TSHA Nasdaq
- Market Cap
- APEI 453.1M
- TSHA 397.8M
- IPO Year
- APEI 2007
- TSHA 2020
- Fundamental
- Price
- APEI $29.45
- TSHA $2.71
- Analyst Decision
- APEI Strong Buy
- TSHA Strong Buy
- Analyst Count
- APEI 5
- TSHA 7
- Target Price
- APEI $30.50
- TSHA $7.00
- AVG Volume (30 Days)
- APEI 249.4K
- TSHA 5.2M
- Earning Date
- APEI 05-12-2025
- TSHA 05-15-2025
- Dividend Yield
- APEI N/A
- TSHA N/A
- EPS Growth
- APEI N/A
- TSHA N/A
- EPS
- APEI 1.02
- TSHA N/A
- Revenue
- APEI $634,678,000.00
- TSHA $7,224,000.00
- Revenue This Year
- APEI $7.12
- TSHA N/A
- Revenue Next Year
- APEI $4.17
- TSHA N/A
- P/E Ratio
- APEI $28.97
- TSHA N/A
- Revenue Growth
- APEI 4.86
- TSHA N/A
- 52 Week Low
- APEI $11.80
- TSHA $1.05
- 52 Week High
- APEI $30.19
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- APEI 65.64
- TSHA 60.38
- Support Level
- APEI $27.90
- TSHA $2.44
- Resistance Level
- APEI $30.19
- TSHA $2.95
- Average True Range (ATR)
- APEI 1.35
- TSHA 0.25
- MACD
- APEI 0.05
- TSHA -0.02
- Stochastic Oscillator
- APEI 84.84
- TSHA 51.60
About APEI American Public Education Inc.
American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.